Antifungal Activities of Antineoplastic Agents: Saccharomyces cerevisiae as a Model System To Study Drug Action
Year: 1999
Type: review
Abstract: Recent evolutionary studies reveal that microorganisms including yeasts and fungi are more closely related to mammals than was previously appreciated. Possibly as a consequence, many natural-product toxins that have antimicrobial activity are also toxic to mammalian cells. While this makes it difficult to discover antifungal agents without toxic side effects, it also has enabled detailed studies of drug action in simple genetic model systems. We review here studies on the antifungal actions of antineoplasmic agents. Topics covered include the mechanisms of action of inhibitors of topoisomerases I and II; the immunosuppressants rapamycin, cyclosporin A, and FK506; the phosphatidylinositol 3-kinase inhibitor wortmannin; the angiogenesis inhibitors fumagillin and ovalicin; the HSP90 inhibitor geldanamycin; and agents that inhibit sphingolipid metabolism. In general, these natural products inhibit target proteins conserved from microorganisms to humans. These studies highlight the potential of microorganisms as screening tools to elucidate the mechanisms of action of novel pharmacological agents with unique effects against specific mammalian cell types, including neoplastic cells. In addition, this analysis suggests that antineoplastic agents and derivatives might find novel indications in the treatment of fungal infections, for which few agents are presently available, toxicity remains a serious concern, and drug resistance is emerging.
Source: Clinical Microbiology Reviews
DOI: 10.1128/cmr.12.4.583
Institutions: Howard Hughes Medical Institute, Duke Medical Center
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: antifungal activity, anticancer agents, Saccharomyces cerevisiae, drug mechanisms of action, topoisomerase inhibitors, immunosuppressants, rapamycin, cyclosporine, FK506, wortmannin, phosphatidylinositol 3-kinase, fumagillin, angiogenesis inhibitors, geldanamycin, Hsp90 inhibitors, fungal infection, drug resistance
Open Access status: green
Awards: Genetics of Cryptococcus sexual reproduction, Role of Calcineurin in Fungal Virulence, G316281995, STRUCTURE/FUNCTION OF THE TARGETS OF RAPAMYCIN--THE, CRYPTOCOCCUS NEOFORMANS--A MODEL FOR PATHOGENIC FUNGI, NOVEL ANTIFUNGAL DRUG TARGETS IN CRYPTOCOCCUS NEOFORMANS, Impact of RNAi and unisexual reproduction on Cryptococcus evolution, drug resistance, and pathogenesis
OpenAlex ID: W2104368376
